Drug recall · February 9, 2022
Tretinoin Capsules recall
Why: Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02
- Lots / codes
Lot #: 100022970, Exp. 08/2022
- Quantity
- 1,175 Bottles
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- nationwide in the USA
- Initiated
- January 10, 2022 · Voluntary: Firm initiated
- Classified
- February 2, 2022
- Reported
- February 9, 2022
- Ended
- December 21, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tretinoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.